Loading…

Can magnesium sulfate prophylaxis reduce colistin nephrotoxicity?

The study aimed to investigate the role of magnesium sulfate prophylaxis in nephrotoxicity caused by colistin. Thirty Wistar Albino rats were divided into four groups: control, colistin, magnesium (Mg), and Mg + colistin. The drugs were administered to the groups for seven days. Urea-creatinine valu...

Full description

Saved in:
Bibliographic Details
Published in:Nefrología 2021-11, Vol.41 (6), p.661-669
Main Authors: Yasemin Coşkun Yavuz, Nihal Cetin, Esma Menevşe, Ahmet Cizmecioglu, Esin Celik, Zeynep Biyik, Can Sevinc, Serkan Yavuz, Muslu Kazim Korez, Lutfullah Altintepe
Format: Article
Language:Spanish
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 669
container_issue 6
container_start_page 661
container_title Nefrología
container_volume 41
creator Yasemin Coşkun Yavuz
Nihal Cetin
Esma Menevşe
Ahmet Cizmecioglu
Esin Celik
Zeynep Biyik
Can Sevinc
Serkan Yavuz
Muslu Kazim Korez
Lutfullah Altintepe
description The study aimed to investigate the role of magnesium sulfate prophylaxis in nephrotoxicity caused by colistin. Thirty Wistar Albino rats were divided into four groups: control, colistin, magnesium (Mg), and Mg + colistin. The drugs were administered to the groups for seven days. Urea-creatinine values were measured at the beginning (T0) and end (T1) of the study. Malondialdehyde (MDA) levels were measured in plasma and kidney tissue, glutathione (GSH) levels were analyzed in the erythrocyte and kidney tissues. At the end of the study, the semiquantitative score (SQS) was calculated by the histopathological examination of the kidneys. Urea values significantly decreased in Mg and Mg + colistin groups compared to the baseline (p = 0.013 and p = 0.001). At the time of T1, these groups had significantly lower urea values than the colistin and control groups. Creatinine value was significantly increased in the colistin group compared to baseline (p = 0.005), the creatinine value in the colistin group was significantly higher than the Mg + colistin group (p = 0.011). Plasma MDA levels were significantly higher in the colistin group compared to the other groups at the time of T1 (p 
format article
fullrecord <record><control><sourceid>doaj</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_048c9fb3d1b542aab59effc00f58d819</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_048c9fb3d1b542aab59effc00f58d819</doaj_id><sourcerecordid>oai_doaj_org_article_048c9fb3d1b542aab59effc00f58d819</sourcerecordid><originalsourceid>FETCH-doaj_primary_oai_doaj_org_article_048c9fb3d1b542aab59effc00f58d8193</originalsourceid><addsrcrecordid>eNqtzEsKwjAUQNEMFPzuIRsQ0trUZiQiis6dh9d82lfSpiQp2N0L4hIcXTiDuyBrlmfZoRSCr8gmxo6xkufitCaXKwy0h2YwEaeexslZSIaOwY_t7OCNkQajJ2Wo8g5jwoEOZmyDT_6NCtN83pGlBRfN_tcted5vr-vjoD10cgzYQ5ilB5Rf8KGREBIqZyQrKiVsfdRZzYscoObCWKsYs7zSVSaO_3x9AJisVOQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Can magnesium sulfate prophylaxis reduce colistin nephrotoxicity?</title><source>ScienceDirect</source><creator>Yasemin Coşkun Yavuz ; Nihal Cetin ; Esma Menevşe ; Ahmet Cizmecioglu ; Esin Celik ; Zeynep Biyik ; Can Sevinc ; Serkan Yavuz ; Muslu Kazim Korez ; Lutfullah Altintepe</creator><creatorcontrib>Yasemin Coşkun Yavuz ; Nihal Cetin ; Esma Menevşe ; Ahmet Cizmecioglu ; Esin Celik ; Zeynep Biyik ; Can Sevinc ; Serkan Yavuz ; Muslu Kazim Korez ; Lutfullah Altintepe</creatorcontrib><description>The study aimed to investigate the role of magnesium sulfate prophylaxis in nephrotoxicity caused by colistin. Thirty Wistar Albino rats were divided into four groups: control, colistin, magnesium (Mg), and Mg + colistin. The drugs were administered to the groups for seven days. Urea-creatinine values were measured at the beginning (T0) and end (T1) of the study. Malondialdehyde (MDA) levels were measured in plasma and kidney tissue, glutathione (GSH) levels were analyzed in the erythrocyte and kidney tissues. At the end of the study, the semiquantitative score (SQS) was calculated by the histopathological examination of the kidneys. Urea values significantly decreased in Mg and Mg + colistin groups compared to the baseline (p = 0.013 and p = 0.001). At the time of T1, these groups had significantly lower urea values than the colistin and control groups. Creatinine value was significantly increased in the colistin group compared to baseline (p = 0.005), the creatinine value in the colistin group was significantly higher than the Mg + colistin group (p = 0.011). Plasma MDA levels were significantly higher in the colistin group compared to the other groups at the time of T1 (p &lt; 0.001). The Mg + colistin group had lower renal MDA levels than the colistin group. The colistin group had significantly higher renal tubular grade (p = 0.035), renal affected area (p &lt; 0.001), and SQS (p = 0.001) than the Mg + colistin group. The results of the study suggested that Mg sulfate may have a nephrotoxicity-reducing effect on colistin. Resumen: El objetivo del estudio fue investigar la función de la profilaxis con sulfato de magnesio en la nefrotoxicidad causada por la colistina. Se dividieron 30 ratas Wistar albinas en 4 grupos: control, colistina, magnesio (Mg) y Mg + colistina. Los fármacos se administraron a los grupos durante 7 días. Los valores de urea-creatinina se midieron al principio (T0) y al final (T1) del estudio. Se midieron los niveles de malondialdehído (MDA) en el plasma y el tejido renal, y se analizaron los niveles de glutatión (GSH) en los eritrocitos y el tejido renal. Al final del estudio, se calculó la puntuación semicuantitativa (semiquantitative score [SQS]) mediante el examen histopatológico de los riñones. Los valores de urea disminuyeron significativamente en los grupos de Mg y Mg + colistina en comparación con los valores iniciales (p = 0,013 y p = 0,001). En el momento del T1, estos grupos tenían valores de urea significativamente más bajos que los grupos de colistina y de control. El valor de creatinina se incrementó significativamente en el grupo de colistina en comparación con el valor inicial (p = 0,005); el valor de creatinina en el grupo de colistina fue significativamente mayor que en el grupo de Mg + colistina (p = 0,011). Los niveles de MDA en el plasma fueron significativamente más altos en el grupo de colistina en comparación con los otros grupos en el momento del T1 (p &lt; 0,001). El grupo de Mg + colistina presentó niveles renales de MDA más bajos que el grupo de colistina. El grupo de colistina presentó un grado tubular renal (p = 0,035), un área renal afectada (p &lt; 0,001) y una SQS (p = 0,001) significativamente mayores que el grupo de Mg + colistina. Los resultados del estudio indicaron que el sulfato de Mg puede tener un efecto reductor de la nefrotoxicidad de la colistina.</description><identifier>ISSN: 0211-6995</identifier><language>spa</language><publisher>Elsevier</publisher><subject>Colistina ; Estrés oxidativo ; Magnesio ; Modelo de rata ; Nefrotoxicidad</subject><ispartof>Nefrología, 2021-11, Vol.41 (6), p.661-669</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids></links><search><creatorcontrib>Yasemin Coşkun Yavuz</creatorcontrib><creatorcontrib>Nihal Cetin</creatorcontrib><creatorcontrib>Esma Menevşe</creatorcontrib><creatorcontrib>Ahmet Cizmecioglu</creatorcontrib><creatorcontrib>Esin Celik</creatorcontrib><creatorcontrib>Zeynep Biyik</creatorcontrib><creatorcontrib>Can Sevinc</creatorcontrib><creatorcontrib>Serkan Yavuz</creatorcontrib><creatorcontrib>Muslu Kazim Korez</creatorcontrib><creatorcontrib>Lutfullah Altintepe</creatorcontrib><title>Can magnesium sulfate prophylaxis reduce colistin nephrotoxicity?</title><title>Nefrología</title><description>The study aimed to investigate the role of magnesium sulfate prophylaxis in nephrotoxicity caused by colistin. Thirty Wistar Albino rats were divided into four groups: control, colistin, magnesium (Mg), and Mg + colistin. The drugs were administered to the groups for seven days. Urea-creatinine values were measured at the beginning (T0) and end (T1) of the study. Malondialdehyde (MDA) levels were measured in plasma and kidney tissue, glutathione (GSH) levels were analyzed in the erythrocyte and kidney tissues. At the end of the study, the semiquantitative score (SQS) was calculated by the histopathological examination of the kidneys. Urea values significantly decreased in Mg and Mg + colistin groups compared to the baseline (p = 0.013 and p = 0.001). At the time of T1, these groups had significantly lower urea values than the colistin and control groups. Creatinine value was significantly increased in the colistin group compared to baseline (p = 0.005), the creatinine value in the colistin group was significantly higher than the Mg + colistin group (p = 0.011). Plasma MDA levels were significantly higher in the colistin group compared to the other groups at the time of T1 (p &lt; 0.001). The Mg + colistin group had lower renal MDA levels than the colistin group. The colistin group had significantly higher renal tubular grade (p = 0.035), renal affected area (p &lt; 0.001), and SQS (p = 0.001) than the Mg + colistin group. The results of the study suggested that Mg sulfate may have a nephrotoxicity-reducing effect on colistin. Resumen: El objetivo del estudio fue investigar la función de la profilaxis con sulfato de magnesio en la nefrotoxicidad causada por la colistina. Se dividieron 30 ratas Wistar albinas en 4 grupos: control, colistina, magnesio (Mg) y Mg + colistina. Los fármacos se administraron a los grupos durante 7 días. Los valores de urea-creatinina se midieron al principio (T0) y al final (T1) del estudio. Se midieron los niveles de malondialdehído (MDA) en el plasma y el tejido renal, y se analizaron los niveles de glutatión (GSH) en los eritrocitos y el tejido renal. Al final del estudio, se calculó la puntuación semicuantitativa (semiquantitative score [SQS]) mediante el examen histopatológico de los riñones. Los valores de urea disminuyeron significativamente en los grupos de Mg y Mg + colistina en comparación con los valores iniciales (p = 0,013 y p = 0,001). En el momento del T1, estos grupos tenían valores de urea significativamente más bajos que los grupos de colistina y de control. El valor de creatinina se incrementó significativamente en el grupo de colistina en comparación con el valor inicial (p = 0,005); el valor de creatinina en el grupo de colistina fue significativamente mayor que en el grupo de Mg + colistina (p = 0,011). Los niveles de MDA en el plasma fueron significativamente más altos en el grupo de colistina en comparación con los otros grupos en el momento del T1 (p &lt; 0,001). El grupo de Mg + colistina presentó niveles renales de MDA más bajos que el grupo de colistina. El grupo de colistina presentó un grado tubular renal (p = 0,035), un área renal afectada (p &lt; 0,001) y una SQS (p = 0,001) significativamente mayores que el grupo de Mg + colistina. Los resultados del estudio indicaron que el sulfato de Mg puede tener un efecto reductor de la nefrotoxicidad de la colistina.</description><subject>Colistina</subject><subject>Estrés oxidativo</subject><subject>Magnesio</subject><subject>Modelo de rata</subject><subject>Nefrotoxicidad</subject><issn>0211-6995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqtzEsKwjAUQNEMFPzuIRsQ0trUZiQiis6dh9d82lfSpiQp2N0L4hIcXTiDuyBrlmfZoRSCr8gmxo6xkufitCaXKwy0h2YwEaeexslZSIaOwY_t7OCNkQajJ2Wo8g5jwoEOZmyDT_6NCtN83pGlBRfN_tcted5vr-vjoD10cgzYQ5ilB5Rf8KGREBIqZyQrKiVsfdRZzYscoObCWKsYs7zSVSaO_3x9AJisVOQ</recordid><startdate>20211101</startdate><enddate>20211101</enddate><creator>Yasemin Coşkun Yavuz</creator><creator>Nihal Cetin</creator><creator>Esma Menevşe</creator><creator>Ahmet Cizmecioglu</creator><creator>Esin Celik</creator><creator>Zeynep Biyik</creator><creator>Can Sevinc</creator><creator>Serkan Yavuz</creator><creator>Muslu Kazim Korez</creator><creator>Lutfullah Altintepe</creator><general>Elsevier</general><scope>DOA</scope></search><sort><creationdate>20211101</creationdate><title>Can magnesium sulfate prophylaxis reduce colistin nephrotoxicity?</title><author>Yasemin Coşkun Yavuz ; Nihal Cetin ; Esma Menevşe ; Ahmet Cizmecioglu ; Esin Celik ; Zeynep Biyik ; Can Sevinc ; Serkan Yavuz ; Muslu Kazim Korez ; Lutfullah Altintepe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-doaj_primary_oai_doaj_org_article_048c9fb3d1b542aab59effc00f58d8193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2021</creationdate><topic>Colistina</topic><topic>Estrés oxidativo</topic><topic>Magnesio</topic><topic>Modelo de rata</topic><topic>Nefrotoxicidad</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yasemin Coşkun Yavuz</creatorcontrib><creatorcontrib>Nihal Cetin</creatorcontrib><creatorcontrib>Esma Menevşe</creatorcontrib><creatorcontrib>Ahmet Cizmecioglu</creatorcontrib><creatorcontrib>Esin Celik</creatorcontrib><creatorcontrib>Zeynep Biyik</creatorcontrib><creatorcontrib>Can Sevinc</creatorcontrib><creatorcontrib>Serkan Yavuz</creatorcontrib><creatorcontrib>Muslu Kazim Korez</creatorcontrib><creatorcontrib>Lutfullah Altintepe</creatorcontrib><collection>Directory of Open Access Journals</collection><jtitle>Nefrología</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yasemin Coşkun Yavuz</au><au>Nihal Cetin</au><au>Esma Menevşe</au><au>Ahmet Cizmecioglu</au><au>Esin Celik</au><au>Zeynep Biyik</au><au>Can Sevinc</au><au>Serkan Yavuz</au><au>Muslu Kazim Korez</au><au>Lutfullah Altintepe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Can magnesium sulfate prophylaxis reduce colistin nephrotoxicity?</atitle><jtitle>Nefrología</jtitle><date>2021-11-01</date><risdate>2021</risdate><volume>41</volume><issue>6</issue><spage>661</spage><epage>669</epage><pages>661-669</pages><issn>0211-6995</issn><abstract>The study aimed to investigate the role of magnesium sulfate prophylaxis in nephrotoxicity caused by colistin. Thirty Wistar Albino rats were divided into four groups: control, colistin, magnesium (Mg), and Mg + colistin. The drugs were administered to the groups for seven days. Urea-creatinine values were measured at the beginning (T0) and end (T1) of the study. Malondialdehyde (MDA) levels were measured in plasma and kidney tissue, glutathione (GSH) levels were analyzed in the erythrocyte and kidney tissues. At the end of the study, the semiquantitative score (SQS) was calculated by the histopathological examination of the kidneys. Urea values significantly decreased in Mg and Mg + colistin groups compared to the baseline (p = 0.013 and p = 0.001). At the time of T1, these groups had significantly lower urea values than the colistin and control groups. Creatinine value was significantly increased in the colistin group compared to baseline (p = 0.005), the creatinine value in the colistin group was significantly higher than the Mg + colistin group (p = 0.011). Plasma MDA levels were significantly higher in the colistin group compared to the other groups at the time of T1 (p &lt; 0.001). The Mg + colistin group had lower renal MDA levels than the colistin group. The colistin group had significantly higher renal tubular grade (p = 0.035), renal affected area (p &lt; 0.001), and SQS (p = 0.001) than the Mg + colistin group. The results of the study suggested that Mg sulfate may have a nephrotoxicity-reducing effect on colistin. Resumen: El objetivo del estudio fue investigar la función de la profilaxis con sulfato de magnesio en la nefrotoxicidad causada por la colistina. Se dividieron 30 ratas Wistar albinas en 4 grupos: control, colistina, magnesio (Mg) y Mg + colistina. Los fármacos se administraron a los grupos durante 7 días. Los valores de urea-creatinina se midieron al principio (T0) y al final (T1) del estudio. Se midieron los niveles de malondialdehído (MDA) en el plasma y el tejido renal, y se analizaron los niveles de glutatión (GSH) en los eritrocitos y el tejido renal. Al final del estudio, se calculó la puntuación semicuantitativa (semiquantitative score [SQS]) mediante el examen histopatológico de los riñones. Los valores de urea disminuyeron significativamente en los grupos de Mg y Mg + colistina en comparación con los valores iniciales (p = 0,013 y p = 0,001). En el momento del T1, estos grupos tenían valores de urea significativamente más bajos que los grupos de colistina y de control. El valor de creatinina se incrementó significativamente en el grupo de colistina en comparación con el valor inicial (p = 0,005); el valor de creatinina en el grupo de colistina fue significativamente mayor que en el grupo de Mg + colistina (p = 0,011). Los niveles de MDA en el plasma fueron significativamente más altos en el grupo de colistina en comparación con los otros grupos en el momento del T1 (p &lt; 0,001). El grupo de Mg + colistina presentó niveles renales de MDA más bajos que el grupo de colistina. El grupo de colistina presentó un grado tubular renal (p = 0,035), un área renal afectada (p &lt; 0,001) y una SQS (p = 0,001) significativamente mayores que el grupo de Mg + colistina. Los resultados del estudio indicaron que el sulfato de Mg puede tener un efecto reductor de la nefrotoxicidad de la colistina.</abstract><pub>Elsevier</pub><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0211-6995
ispartof Nefrología, 2021-11, Vol.41 (6), p.661-669
issn 0211-6995
language spa
recordid cdi_doaj_primary_oai_doaj_org_article_048c9fb3d1b542aab59effc00f58d819
source ScienceDirect
subjects Colistina
Estrés oxidativo
Magnesio
Modelo de rata
Nefrotoxicidad
title Can magnesium sulfate prophylaxis reduce colistin nephrotoxicity?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T23%3A29%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-doaj&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Can%20magnesium%20sulfate%20prophylaxis%20reduce%20colistin%20nephrotoxicity?&rft.jtitle=Nefrolog%C3%ADa&rft.au=Yasemin%20Co%C5%9Fkun%20Yavuz&rft.date=2021-11-01&rft.volume=41&rft.issue=6&rft.spage=661&rft.epage=669&rft.pages=661-669&rft.issn=0211-6995&rft_id=info:doi/&rft_dat=%3Cdoaj%3Eoai_doaj_org_article_048c9fb3d1b542aab59effc00f58d819%3C/doaj%3E%3Cgrp_id%3Ecdi_FETCH-doaj_primary_oai_doaj_org_article_048c9fb3d1b542aab59effc00f58d8193%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true